Tumor Immune Microenvironment of EGFR -mutant Non-Small-Cell Lung Cancer and its Impact on Therapeut...
Tumor Immune Microenvironment of EGFR -mutant Non-Small-Cell Lung Cancer and its Impact on Therapeutic Efficacy
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
[...]these studies excluded patients with EGFR mutations from the KEYNOTE-024, KEYNOTE-042 and KEYNOTE-189 trials, including TKI-naive EGFR-mutant patients from the IMpower150 trial, perhaps due to the above mentioned background (16-18,20). [...]the therapeutic impact of immunotherapy as a first-line treatment option for patients with EGFR-activati...
Alternative Titles
Full title
Tumor Immune Microenvironment of EGFR -mutant Non-Small-Cell Lung Cancer and its Impact on Therapeutic Efficacy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2501457299
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501457299
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt-2019-0213
